Introduction
Gavi, the Vaccine Alliance is a major international public-private health partnership dedicated to increasing access to immunization and life-saving vaccines for children in the world’s poorest countries. Created in 2000, Gavi works to protect vulnerable populations from vaccine-preventable diseases and strengthen health systems worldwide. Headquartered in Geneva, Switzerland, the Alliance draws on global cooperation between governments, international agencies, foundations, manufacturers, civil society, and private partners.
History and Background
Gavi was established in 2000 in response to stagnating immunization rates in low-income countries and mounting evidence that vaccines could dramatically reduce child mortality and improve population health. It grew out of a global effort to improve access to routine vaccinations and expand coverage of new and under-used vaccines. Over the past two decades, Gavi has played a transformative role in global health by facilitating vaccine introductions, helping countries increase immunization coverage, and shaping vaccine markets to reduce costs.
Mission and Purpose
Gavi’s mission is clear: to save lives and protect people’s health by increasing equitable and sustainable use of vaccines in lower-income countries. The Alliance aims to:
- Expand routine immunization coverage
- Ensure equitable access to both existing and new vaccines
- Strengthen national immunization and primary health care systems
- Support sustainable financing for immunization programmes
- Make vaccines affordable and widely available through market-shaping mechanisms
Since its launch, Gavi has helped protect whole generations of children, immunizing more than 1.2 billion children and preventing upwards of 20.6 million future deaths in 78 lower-income countries.
Governance and Structure
Gavi operates as a multistakeholder alliance bringing together a range of global partners, including:
- Developing country governments
- Donor governments and international agencies
- World Health Organization (WHO)
- United Nations Children’s Fund
- World Bank
- Bill & Melinda Gates Foundation and other philanthropic partners
- Civil society organizations (CSOs)
- Vaccine manufacturers and technical health institutes
This collaborative governance model leverages expertise from both public and private sectors — combining technical leadership, financing know-how, on-the-ground insights, and market influence.
Funding and Financial Model
Unlike traditional donors or grant-making foundations, Gavi is funded through collective contributions from a wide range of global donors, including:
- Sovereign governments
- Multilateral organizations
- Corporate partners and private foundations
- Individual and institutional contributions
Funding supports immunization programmes, vaccine procurement, health system strengthening, technical assistance, and market-shaping initiatives that reduce vaccine prices for low-income countries. Gavi operates in multi-year financing cycles — each with strategic goals tied to specific immunization and health outcomes.
Core Activities and Programs
Vaccine Introduction and Coverage Expansion
Gavi assists countries in introducing new vaccines into routine immunization schedules, including those for pneumococcal disease, rotavirus, HPV, malaria, meningitis, and Ebola. The Alliance’s support significantly expands vaccination coverage among children, especially in underserved and remote communities.
Health System Strengthening
The Alliance invests in improving primary healthcare infrastructure, cold chain systems, trained health workforces, data systems, and routine immunization service delivery. These efforts help ensure vaccines reach every child and reinforce broader health systems.
Market Shaping
Gavi works with manufacturers to reduce vaccine prices, ensure sustainable supply, and speed up access to new vaccine technologies. This includes negotiating advanced market commitments and other procurement mechanisms that make vaccines more affordable for low-income countries.
Civil Society and Community Engagement
The Alliance partners with civil society organizations (CSOs) to reach hard-to-reach populations, address vaccine hesitancy, and tailor immunization programmes to local needs. Grants and technical support help CSOs extend immunization coverage to zero-dose children — those who have never received even a single vaccine.
Impact and Global Reach
Gavi’s impact is profound and measurable:
- More than 1.2 billion children immunized since 2000
- An estimated 20 + million future deaths prevented through vaccine programmes
- Support for vaccines targeting over 20 infectious diseases
- Significant reductions in child mortality and disease burden in low-income nations
- Vast economic benefits — vaccines deliver high returns by enabling healthier, more productive populations
Beyond saving lives, Gavi’s work contributes to economic growth, education participation, and poverty reduction, as healthier children and families strengthen whole communities.
Major Initiatives and Future Directions
Strategic Goals (2026–2030)
In its current planning cycle, Gavi is pursuing ambitious goals, including reaching hundreds of millions more children, expanding vaccine access, and accelerating equitable coverage — especially among the most vulnerable populations. These efforts are expected to prevent millions more deaths and create sustainable vaccination programmes in partner countries.
The Alliance also collaborates with partners like the World Bank Group to promote regional vaccine manufacturing and financial resilience, mobilizing billions in joint financing to strengthen immunization infrastructure.
Conclusion
Gavi, the Vaccine Alliance is a cornerstone global health partnership that has transformed immunization access in the world’s poorest countries. Through collaboration, innovation, and strategic funding, the Alliance helps protect children from deadly infectious diseases while strengthening health systems and advancing equity. As a hybrid public-private partnership, Gavi’s ongoing work will remain critical to reaching unvaccinated children, reducing preventable deaths, and building healthier, more resilient communities worldwide.
for more information, visit here.
